155 related articles for article (PubMed ID: 33458399)
1. Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features.
Dinis Fernandes C; Dinh CV; Walraven I; Heijmink SW; Smolic M; van Griethuysen JJM; Simões R; Losnegård A; van der Poel HG; Pos FJ; van der Heide UA
Phys Imaging Radiat Oncol; 2018 Jul; 7():9-15. PubMed ID: 33458399
[TBL] [Abstract][Full Text] [Related]
2. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
3. Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings.
Zhong J; Frood R; McWilliam A; Davey A; Shortall J; Swinton M; Hulson O; West CM; Buckley D; Brown S; Choudhury A; Hoskin P; Henry A; Scarsbrook A
Radiol Med; 2023 Jun; 128(6):765-774. PubMed ID: 37198374
[TBL] [Abstract][Full Text] [Related]
4. Treatment response prediction using MRI-based pre-, post-, and delta-radiomic features and machine learning algorithms in colorectal cancer.
Shayesteh S; Nazari M; Salahshour A; Sandoughdaran S; Hajianfar G; Khateri M; Yaghobi Joybari A; Jozian F; Fatehi Feyzabad SH; Arabi H; Shiri I; Zaidi H
Med Phys; 2021 Jul; 48(7):3691-3701. PubMed ID: 33894058
[TBL] [Abstract][Full Text] [Related]
5. Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy.
Dutta A; Chan J; Haworth A; Dubowitz DJ; Kneebone A; Reynolds HM
Phys Imaging Radiat Oncol; 2024 Jan; 29():100530. PubMed ID: 38275002
[TBL] [Abstract][Full Text] [Related]
6. Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients.
Wu S; Jiao Y; Zhang Y; Ren X; Li P; Yu Q; Zhang Q; Wang Q; Fu S
Cancer Manag Res; 2019; 11():9121-9131. PubMed ID: 31695500
[TBL] [Abstract][Full Text] [Related]
7. Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy.
Lee SL; Ravi A; Morton G; Loblaw A; Tseng CL; Haider M; Murgic J; Nicolae A; Semple M; Chung HT
Brachytherapy; 2019; 18(5):567-573. PubMed ID: 31126856
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.
Zhang G; Zhang Z; Pei Y; Hu W; Xue Y; Ning R; Guo X; Sun Y; Zhang Q
Front Endocrinol (Lausanne); 2023; 14():1272806. PubMed ID: 38027108
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
10. Haralick textural features on T
Gnep K; Fargeas A; Gutiérrez-Carvajal RE; Commandeur F; Mathieu R; Ospina JD; Rolland Y; Rohou T; Vincendeau S; Hatt M; Acosta O; de Crevoisier R
J Magn Reson Imaging; 2017 Jan; 45(1):103-117. PubMed ID: 27345946
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
12. External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer.
Bourbonne V; Fournier G; Vallières M; Lucia F; Doucet L; Tissot V; Cuvelier G; Hue S; Le Penn Du H; Perdriel L; Bertrand N; Staroz F; Visvikis D; Pradier O; Hatt M; Schick U
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32231077
[TBL] [Abstract][Full Text] [Related]
13. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
[TBL] [Abstract][Full Text] [Related]
14. Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy.
Zhong QZ; Long LH; Liu A; Li CM; Xiu X; Hou XY; Wu QH; Gao H; Xu YG; Zhao T; Wang D; Lin HL; Sha XY; Wang WH; Chen M; Li GF
Front Oncol; 2020; 10():731. PubMed ID: 32477949
[No Abstract] [Full Text] [Related]
15. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics.
Chen W; Wang S; Dong D; Gao X; Zhou K; Li J; Lv B; Li H; Wu X; Fang M; Tian J; Xu M
Front Oncol; 2019; 9():1265. PubMed ID: 31824847
[No Abstract] [Full Text] [Related]
17. Rectal wall MRI radiomics in prostate cancer patients: prediction of and correlation with early rectal toxicity.
Abdollahi H; Mahdavi SR; Mofid B; Bakhshandeh M; Razzaghdoust A; Saadipoor A; Tanha K
Int J Radiat Biol; 2018 Sep; 94(9):829-837. PubMed ID: 29969358
[TBL] [Abstract][Full Text] [Related]
18. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
19. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
